发明公开
EP1848432A4 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF DISEASES INVOLVING OBESITY, DIABETES, METABOLIC SYNDROME, NEURO-DEGENERATIVE DISEASES AND MITOCHONDRIA DYSFUNCTION DISEASES
有权
药物组合物治疗或疾病的预防与肥胖，糖尿病，代谢综合征，神经退行性疾病，线粒体疾病MALFUNCTION连词
- 专利标题： PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF DISEASES INVOLVING OBESITY, DIABETES, METABOLIC SYNDROME, NEURO-DEGENERATIVE DISEASES AND MITOCHONDRIA DYSFUNCTION DISEASES
- 专利标题（中）： 药物组合物治疗或疾病的预防与肥胖，糖尿病，代谢综合征，神经退行性疾病，线粒体疾病MALFUNCTION连词
-
申请号： EP06715982申请日： 2006-02-15
-
公开(公告)号： EP1848432A4公开(公告)日： 2009-12-30
- 发明人: YOO SANG-KU , PARK MYUNGGYU , JO IN GEUN , KWAK TAEHWAN
- 申请人： MD BIOALPHA CO LTD , KT & G CO LTD
- 专利权人： MD BIOALPHA CO LTD,KT & G CO LTD
- 当前专利权人： MD BIOALPHA CO LTD,KT & G CO LTD
- 优先权： KR20050012625 2005-02-16
- 主分类号： A61P3/04
- IPC分类号： A61P3/04 ; A61K31/352 ; A61K31/353 ; A61P1/16 ; A61P3/00 ; A61P3/10 ; A61P9/10 ; A61P9/12 ; A61P27/02 ; A61P29/00
摘要：
Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.
信息查询
